Business
AYURCANN REPORTS Q1 2026 SALES OF $14,638,697
Toronto, Ontario, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”) is excited to announce its financial and operational results for the three months ended September 30, 2025, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company’s full set of unaudited condensed interim consolidated financial statements for the three months ended September 30, 2025 and accompanying mana
About this update from Ayurcann Holdings Corp.
[{"type":"image","alt":"Ayurcann Holdings Corp.","displaySize":"","headline":null,"caption":"Ayurcann Holdings Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":203,"height":191,"url":"https://media.zenfs.com/en/globenewswire.com/269152d55308912eddb9304883eacb65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/WB2uH.vK1Y8HU7wcX7rNLw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2MDtoPTMzOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/269152d55308912eddb9304883eacb65","width":203,"height":191}},"lazy":false},{"type":"text","content":"Toronto, Ontario, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”) is excited to announce its financial and operational results for the three months ended September 30, 2025, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company’s full set of unaudited condensed interim consolidated financial statements for the three months ended September 30, 2025 and accompanying management’s discussion and analysis can be accessed by visiting the Company’s website at www.ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca.","length":654,"tagName":"p"},{"type":"text","content":"Q1 2026 Highlights: Consistent Execution","length":40,"tagName":"p"},{"type":"text","content":"Revenue: Ayurcann generated $14,638,697 in gross revenue, with gross profit of $2,236,343 and a healthy gross margin of 26% in Q1 2026 (vs. $14,657,485 in gross revenue, with gross profit of $3,321,974 and a gross margin of 40% in Q1 2025), reflecting continued robust demand across our expanding product categories and successful national distribution efforts.","length":361,"tagName":"p"},{"type":"text","content":"Market Share Leadership: Ayurcann is now recognized as a Top 3 vape producer in Ontario by volume, with a 5% share of the national vape market and 7% share in Ontario, underscoring our dominance in one of Canada’s fastest-growing categories.1","length":242,"tagName":"p"},{"type":"text","content":"A High-Performance Operator","length":27,"tagName":"p"},{"type":"text","content":"Operational Discipline: Ayurcann has emerged as one of Canada’s most efficient and reliable cannabis manufacturers, consistently delivering strong output, quality, and on-time execution.","length":186,"tagName":"p"},{"type":"text"...